e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Cellular and molecular mechanisms of COPD and emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses
Robert Foronjy (Scarsdale, United States of America), Pius Ochieng, Patrick Geraghty, Edward Eden, Michael Campos, Robert Foronjy
Source:
International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Session:
Cellular and molecular mechanisms of COPD and emphysema
Session type:
Poster Discussion
Number:
5053
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robert Foronjy (Scarsdale, United States of America), Pius Ochieng, Patrick Geraghty, Edward Eden, Michael Campos, Robert Foronjy. Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses. Eur Respir J 2015; 46: Suppl. 59, 5053
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Inflammation induced conformational changes in Z alpha-1 antirypsin promotes lung Z-AT cell damage
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
GRP78 is a novel receptor initiating endothelial barrier protective response to oxidized phospholipids
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Oxidative stress in TGF-β1-mediated fibrosis in Z alpha-1 antitrypsin cells
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Loss of plasma phospholipid transfer protein (PLTP) activity enhances inflammatory responses to cigarette smoke in the lung
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vitro
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Role of peroxiredoxin 6 in lipopolysaccharide-induced mucin production in mice
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
Plant Kunitz proteinase inhibitor attenuates inflammation, oxidative stress and remodeling induced by elastase in mice
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury
Source: Eur Respir J 2008; 32: 862-870
Year: 2008
Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights
Source: Eur Respir J 2009; 33: 475-488
Year: 2009
Acute phase protein alpha1-antitrypsin - A novel regulator of angiopoietin-like protein 4 transcription and secretion in human cells
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Neutrophil elastase gene expression and relation with lung function in Alpha-1 Antitrypsin deficiency patients.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents
Source: Eur Respir J 2008; 31: 252-260
Year: 2008
New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD
Source: Annual Congress 2005 - Protease-antiprotease revisited
Year: 2005
A molecule derived from mycobacterium tuberculosis
Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Oxidative stress in serum of patients with alpha-1 antitrypsin deficiency
Source: Annual Congress 2013 –New perspectives of lung function assessment in children
Year: 2013
SIRT1 contributes to LPS-induced lung injury through interaction with mitochondrial ROS generation
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept